Peptides as key components in the design ofnon‐viralvectors for gene delivery

Abstract

Successful clinical implementation of gene delivery relies on the use of viral or non‐viral based vectors to package and protect the therapeutic nucleic acid. These vehicles must also be able to direct the fate of the cargo once it has entered the cell to ensure that the nucleic acid is functional, and the desired outcome is achieved. Compared to viral vectors, non‐viral vectors have the advantage of incorporating different material types such as lipids, polymers, and peptides to tune overall safety and efficacy. Peptides are especially powerful when used in gene delivery vectors as they are able to increase gene delivery efficacy by introducing new biochemical functionality. This review will discuss the use of peptides as central design components in non‐viral gene delivery vectors. The contribution of the peptide component to the overall functionality of the delivery vehicle will be highlighted, with a focus on peptides as the only vehicle component or peptides in complex assemblies with lipids or polymers.

Document Details

Document Type
Pub Defense Publication
Publication Date
Sep 18, 2020
Source ID
10.1002/pep2.24189

Entities

People

  • Jin K Montclare
  • Joseph Thomas
  • Kamia Punia

Organizations

  • Army Research Office
  • Division of Materials Research
  • National Center for Advancing Translational Sciences
  • New York University
  • State University of New York

Tags

Readers

  • Distributed Systems and Data Platform Development
  • Infectious Disease/Epidemiology
  • Microbial Pathology

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech